Dose Ranging Pharmacokinetics and Brain Distribution of Norfloxacin Using Microdialysis in Rats

Journal of Pharmaceutical Sciences

Volumn 92, Issue 12, 2003, Pages 2458-2465

  Marchand, Sandrine ^a   Chenel, Marylore ^a   Lamarche, Isabelle ^a   Pariat, Claudine ^a   Couet, William ^a  

^a Pole Biologie Sante   (France)

Author keywords

CNS; Fluoroquinolones; Microdialysis; Norfloxacin; Pharmacokinetics

Indexed keywords

CIPROFLOXACIN; ENOXACIN; NORFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CALIBRATOR; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; EXTRACELLULAR FLUID; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; PLASMA CLEARANCE; RAT; STANDARD; TISSUE DISTRIBUTION;

EID: 0344443703     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10504     Document Type: Article

References (27)

1. De Sarro A, De Sarro G. 2001. Adverse reactions to fluoroquinolones. An overview on mechanistic aspects. Curr Med Chem 8:371-384.
2. Christ W. 1990. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother 26:219-225.
3. Delon A, Huguet F, Courtois Ph, Vierfond JM, Bouquet S, Couet W. 1997. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats. J Pharmacol Exp Ther 280:983-987.
4. Jaehde U, Goto T, de Boer AG Breimer DD. 1993. Blood-brain barrier transport rate of quinolone antibacterials evaluated in cerebrovascular endothelial cell cultures. Eur J Pharm Sci 1:49-55.
5. Jaehde U, Langemeijer MWE, de Boer AG, Breimer DD. 1992. Cerebrospinal fluid transport and disposition of the quinolones ciprofloxacin and pefloxacin in rats. J Pharmacol Exp Ther 263:1140-1146.
6. Ooie T, Suzuki H, Terasaki T, Sugiyama Y. 1996. Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs. Pharm Res 13:523-527.
7. Ooie T, Suzuki H, Terasaki T, Sugiyama Y. 1997. Quantitative brain microdialysis study on mechanism of quinolones distribution in the central nervous system. Drug Metabol Dispos 25:784-789.
8. Delon A, Bouquet S, Huguet F, Brunet V, Courtois Ph. Couet W. 1999. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats. Antimicrob Agents Chemother 43:1511-1515.
9. Cormet-Boyaka E, Huneau JF, Mordrelle A, Boyaka PN, Carbon C, Rubinstein E, Tome T. 1998. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob Agents Chemother 42:2607-2611.
10. Ito T, Yano I, Tanaka K, Inui K-I. 1997. Transport of quinolone antibacterial drugs by human P-glycoprotein expressed in a kidney epithelial cell line LLC-PK1. J Pharmacol Exp Ther 282:955-960.
11. de Lange ECM, Marchand S, van den Berg DJ, van der Sandt ICJ, de Boer AG, Delon A, Bouquet S, Couet W. 2000. In vitro and in vivo investigations on fluoroquinolones; effect of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin. Eur J Pharm Sci 12:85-93.
12. Tamai I, Yamashita J, Kido Y, Ohnari A, Sai Y, Shima Y, Naruhashi K, Koizumi S, Tsuji A. 2000. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at blood-brain barrier. J Pharmacol Exp Ther 295:146-152.
13. Murata M, Tamai I, Kato H, Nagata O, Kato H, Tsuji A. 1999. Efflux transport of new antibacterial agent HSR-903, across the blood-brain barrier. J Pharmacol Exp Ther 290:51-57.
14. Marchand S, Pariat C, Bouquet S, Courtois Ph, Couet W. 2000. Pharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats. Br J Pharmacol 129:1609-1616.
15. Hammarlund-Udenaes M, Paalzow LK, de Lange EC. 1997. Drug equilibration across the blood-brain barrier. Pharmacokinetic considerations based on the microdialysis method. Pharm Res 14:128-134.
16. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. San Diego, CA: Academic Press Inc.
17. Moghaddam B, Bunney BS. 1989. Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basolateral outflow of striatal dopamine. J Neurochem 53:652-654.
18. Lonnroth P, Jansson P-A, Smit U. 1987. A microdialysis method allowing characterization of intracellular water space in humans. Am Physiol Soc 253:E228-E231.
19. Wang Y, Wong SL, Sawchuck RJ. 1993. Microdialysis calibration using retrodialysis and zero net flux: Application to a study of the distribution of zidovudine to rabbit cerebrospinal fluid and thalamus. Pharm Res 10:1411-1419.
20. Yang H, Wang Q, Elmquist W. 1996. Fluconazole distribution to the brain: A crossover study in freely-moving rats using in vivo microdialysis. Pharm Res 13:1570-1575.
21. Wang Y, Welty DF. 1996. The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using microdialysis-pharmacokinetic approach. Pharm Res 13:398-403.
22. Bouw MR, Hammarlund-Udenaes M. 1998. Methodological aspects of the use of calibrator in in vivo microdialysis - Further development of retrodialysis method. Pharm Res 15:1673-1679.
23. Xie R, Hammarlund-Udenaes M. 1998. Blood-brain barrier equilibration of codeine in rats studied with microdialysis. Pharm Res 15:570-575.
24. Ito Y, Ishige K, Aizawa M, Fukuda H. 1999. Characterization of quinolone antibacterial-induced convulsions and increase AP-1 DNA and CRE-binding activites in mouse brain. Neuropharmacology 38:717-723.
25. Davis JD, Aarons L, Houston JB. 1995. Effect of norfloxacin on theophylline disposition: A comparison with other quinolones. Pharm Res 12:257-262.
26. Cavet ME, West M, Simmons NL. 1997. Fluoroquinolone (ciprofloxacin) secretion by human epithelial (Caco-2) cells. Br J Pharmacol 121:1567-1578.
27. Dautrey S, Felice K, Petiet A, Lacour B, Carbon C, Farinotti R. 1999. Active intestinal elimination of ciprofloxacin in rats: Modulation by different substrates. Br J Pharmacol 127:1728-1734.